Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to find best catheter for fragile newborns

NCT ID NCT07209670

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two types of thin tubes (catheters) used to give medicine and nutrition to sick newborns in the intensive care unit. Researchers will track 360 babies to see which catheter type causes fewer infections, lasts longer, and leads to fewer complications. The goal is to provide clear evidence to help doctors make the best choice for each baby.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors choose the safer, longer-lasting catheter type for newborns, reducing infections and complications.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve health, and results may not apply to all hospitals or babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Neonates admitted to the Neonatal Intensive Care Unit (NICU) at Assiut University Children's Hospital who require central venous access for parenteral nutrition, intravenous medications, or frequent blood sampling. Participants will include infants receiving either an umbilical venous catheter (UVC) or a peripherally inserted central catheter (PICC) within the first 28 days of life

Ages

0 to 28 days

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Neonates admitted to the neonatal intensive care unit (NICU) requiring central venous access. * Infants in whom either an umbilical venous catheter (UVC) or a peripherally inserted central catheter (PICC) was inserted for clinical indications (Parenteral nutrition, administration of intravenous medications (e.g., antibiotics, inotropes, anticonvulsants, fluids) and blood sampling for frequent labs, especially in critically ill neonates). * Catheter insertion performed within the first 28 days of life. Exclusion Criteria: * Neonates with major congenital anomalies (e.g.abdominal wall defects) that may interfere with catheter placement or outcomes. * Insertion site infection * Infants with severe coagulopathy or bleeding disorders contraindicating central catheter insertion. * Neonates who received both UVC and PICC simultaneously during the same admission. * Cases with incomplete clinical records or missing follow-up data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clabsi - central line associated bloodstream infection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clabsi - central line associated bloodstream infection Peripherally inserted central catheter Umbilical venous catheter

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.